Treace Medical Concepts Stock Analysis
TMCI Stock | USD 10.28 0.26 2.47% |
Treace Medical Concepts is undervalued with Real Value of 11.2 and Target Price of 9.05. The main objective of Treace Medical stock analysis is to determine its intrinsic value, which is an estimate of what Treace Medical Concepts is worth, separate from its market price. There are two main types of Treace Medical's stock analysis: fundamental analysis and technical analysis.
The Treace Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Treace Medical's ongoing operational relationships across important fundamental and technical indicators.
Treace |
Treace Stock Analysis Notes
About 26.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.99. Treace Medical Concepts had not issued any dividends in recent years. Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida. Treace Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 248 people. To find out more about Treace Medical Concepts contact John Treace at 904 373 5940 or learn more at https://www.treace.com.Treace Medical Quarterly Total Revenue |
|
Treace Medical Concepts Investment Alerts
Treace Medical had very high historical volatility over the last 90 days | |
The company reported the previous year's revenue of 187.12 M. Net Loss for the year was (49.53 M) with profit before overhead, payroll, taxes, and interest of 163.53 M. | |
Treace Medical Concepts currently holds about 101.53 M in cash with (34.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. | |
Roughly 65.0% of the company shares are owned by institutional investors | |
Latest headline from gurufocus.com: Morgan Stanley Reduces Stake in Treace Medical Concepts Inc |
Treace Medical Concepts Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Treace Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024 Upcoming Quarterly Report | View | |
13th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
27th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Treace Largest EPS Surprises
Earnings surprises can significantly impact Treace Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-02-27 | 2023-12-31 | -0.09 | -0.1 | -0.01 | 11 | ||
2021-05-25 | 2021-03-31 | -0.06 | -0.07 | -0.01 | 16 | ||
2021-08-05 | 2021-06-30 | -0.12 | -0.1 | 0.02 | 16 |
Treace Medical Environmental, Social, and Governance (ESG) Scores
Treace Medical's ESG score is a quantitative measure that evaluates Treace Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Treace Medical's operations that may have significant financial implications and affect Treace Medical's stock price as well as guide investors towards more socially responsible investments.
Treace Stock Institutional Investors
Shares | State Street Corp | 2024-09-30 | 997.5 K | Soleus Capital Management, L.p. | 2024-09-30 | 887.9 K | Goldman Sachs Group Inc | 2024-09-30 | 665.2 K | Millennium Management Llc | 2024-09-30 | 554.5 K | Kornitzer Capital Management Inc | 2024-09-30 | 526.9 K | Gagnon Advisors, Llc | 2024-12-31 | 489.9 K | Northern Trust Corp | 2024-09-30 | 458.2 K | Marshall Wace Asset Management Ltd | 2024-09-30 | 426.7 K | Nuveen Asset Management, Llc | 2024-09-30 | 424.3 K | Armistice Capital, Llc | 2024-09-30 | 6.2 M | Blackrock Inc | 2024-09-30 | 4.2 M |
Treace Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 640.41 M.Treace Profitablity
The company has Profit Margin (PM) of (0.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.34) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.34.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.25) | (0.26) | |
Return On Capital Employed | (0.29) | (0.30) | |
Return On Assets | (0.23) | (0.24) | |
Return On Equity | (0.32) | (0.34) |
Management Efficiency
Treace Medical Concepts has return on total asset (ROA) of (0.1713) % which means that it has lost $0.1713 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5069) %, meaning that it created substantial loss on money invested by shareholders. Treace Medical's management efficiency ratios could be used to measure how well Treace Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.26. The current Return On Capital Employed is estimated to decrease to -0.3. As of now, Treace Medical's Other Current Assets are increasing as compared to previous years. The Treace Medical's current Debt To Assets is estimated to increase to 0.51, while Net Tangible Assets are projected to decrease to under 39 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 2.04 | 2.14 | |
Tangible Book Value Per Share | 1.72 | 1.80 | |
Enterprise Value Over EBITDA | (19.22) | (18.26) | |
Price Book Value Ratio | 6.47 | 6.15 | |
Enterprise Value Multiple | (19.22) | (18.26) | |
Price Fair Value | 6.47 | 6.15 | |
Enterprise Value | 958.2 M | 1.3 B |
Treace Medical showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Technical Drivers
As of the 7th of February, Treace Medical has the Risk Adjusted Performance of 0.1981, semi deviation of 2.14, and Coefficient Of Variation of 438.17. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Treace Medical Concepts, as well as the relationship between them.Treace Medical Concepts Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Treace Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Treace Medical Concepts. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Treace Medical Concepts Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Treace Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Treace Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Treace Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Treace Medical Outstanding Bonds
Treace Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Treace Medical Concepts uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Treace bonds can be classified according to their maturity, which is the date when Treace Medical Concepts has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View |
Treace Medical Predictive Daily Indicators
Treace Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Treace Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 17689.02 | |||
Daily Balance Of Power | (0.55) | |||
Rate Of Daily Change | 0.98 | |||
Day Median Price | 10.4 | |||
Day Typical Price | 10.36 | |||
Price Action Indicator | (0.25) | |||
Period Momentum Indicator | (0.26) |
Treace Medical Corporate Filings
3rd of February 2025 Other Reports | ViewVerify | |
F4 | 24th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 14th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 13th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 5th of December 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 13th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Treace Medical Forecast Models
Treace Medical's time-series forecasting models are one of many Treace Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Treace Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Treace Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Treace Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Treace shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Treace Medical. By using and applying Treace Stock analysis, traders can create a robust methodology for identifying Treace entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.30) | (0.32) | |
Operating Profit Margin | (0.32) | (0.33) | |
Net Loss | (0.30) | (0.32) | |
Gross Profit Margin | 0.73 | 0.64 |
Current Treace Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Treace analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Treace analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
9.05 | Buy | 7 | Odds |
Most Treace analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Treace stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Treace Medical Concepts, talking to its executives and customers, or listening to Treace conference calls.
Treace Stock Analysis Indicators
Treace Medical Concepts stock analysis indicators help investors evaluate how Treace Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Treace Medical shares will generate the highest return on investment. By understating and applying Treace Medical stock analysis, traders can identify Treace Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 19.5 M | |
Long Term Debt | 53 M | |
Common Stock Shares Outstanding | 60.9 M | |
Total Stockholder Equity | 137.9 M | |
Property Plant And Equipment Net | 31.6 M | |
Cash And Short Term Investments | 123.2 M | |
Cash | 13 M | |
Accounts Payable | 11.8 M | |
Net Debt | 57.3 M | |
50 Day M A | 8.2596 | |
Total Current Liabilities | 45 M | |
Other Operating Expenses | 238.5 M | |
Non Current Assets Total | 53.5 M | |
Non Currrent Assets Other | 146 K | |
Stock Based Compensation | 17.4 M |
Complementary Tools for Treace Stock analysis
When running Treace Medical's price analysis, check to measure Treace Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Treace Medical is operating at the current time. Most of Treace Medical's value examination focuses on studying past and present price action to predict the probability of Treace Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Treace Medical's price. Additionally, you may evaluate how the addition of Treace Medical to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |